Stock 4114 SYNMOSA BIOPHARMA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Synmosa Biopharma Corporation

Equities

4114

TW0004114004

End-of-day quote Taipei Exchange
Other stock markets
 18:00:00 2024-05-13 EDT 		5-day change 1st Jan Change
39.65 TWD +0.25% Intraday chart for Synmosa Biopharma Corporation +1.41% +2.59%
03-29 Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
01-16 Synmosa Biopharma Corporation Announces Changes in Fifth Session of the Remuneration Committee CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Synmosa Biopharma : The Company is invited to attend institutional investor conference held by IBF Securities
PU
Synmosa Biopharma : To announces SYNMOSA board of directors has lifted the restriction on the prohibition of competition for managerial officer
PU
Synmosa Biopharma : The Company's 2022 Second quarter consolidated financial statements have been reported to the Board
PU
Synmosa Biopharma : Announcement of the Company's adjustment of the number for the transfer treasury shares to employees through the resolution of the board of directors on 7/29
PU
Synmosa Biopharma : Announcement of the Company's board of directors resolution on transfer treasury shares to employees and the record date of share subscription
PU
Synmosa Biopharma : Clarification of Commercial Times news reports
PU
Synmosa Biopharma : board of directors announce the fifth session of the Compensation Committee of the Company
PU
Synmosa Biopharma : announces the record date for 2021 dividend through retained earning.
PU
Synmosa Biopharma : Announcement by Synmosa to dispose Real property. (Update sale profit and loss)
PU
Synmosa Biopharma : The Company is invited to attend Online Investment Forum held by First Securities Inc.
PU
Synmosa Biopharma : Announcement of the second session of the audit committee and the fourth session of the compensation committee of the Company Term Expiration Matters
PU
Synmosa Biopharma : 2022 Shareholders' Meeting approved the “lifting of non-competition restrictions on newly appointed directors and their representatives”case.
PU
Synmosa Biopharma : Announcement of the election of the chairman of the board of directors of the company
PU
Synmosa Biopharma : 2022 Shareholders' Meeting Major Resolutions Shareholders' Meeting
PU
Synmosa Biopharma : Announcement the re-election of Directors (Including Independent Directors) of the Company
PU
Synmosa Biopharma : Announcement of change in the Company's accounting officer and financial officer
PU
Synmosa Biopharma : Board of Directors resolved to buy back common stocks
PU
Synmosa Biopharma : Board of Directors approved dividend distribution
PU
Synmosa Biopharma : The Board of Synmosa resolves to increase capital stock by earnings recapitalization
PU
Synmosa Biopharma : The Company's 2021 consolidated financial statements have been reported to the Board
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4114 Stock
  4. News Synmosa Biopharma Corporation
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW